Laura Anne Lee MD
Breast, Surgical Oncology (Other than Breast), Trauma Surgery & Surgical Critical Care
Physician
Join to View Full Profile
1180 N Indian Canyon DrSuite E218Palm Springs, CA 92262
Phone+1 760-992-7217
Fax+1 760-992-7217
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Breast Surgical Oncology, 2005 - 2006
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Surgical Critical Care, 1998 - 1999- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Surgery, 1992 - 1998
University of Tennessee Health Science Center College of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 2005 - 2026
VA State Medical License 2004 - 2006
AL State Medical License 2002 - 2005
NJ State Medical License 1994 - 2003
PA State Medical License 1994 - 1994
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 1 citationsCombined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01 - 3 citationsGenomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky
JCO Precision Oncology. 2022-09-01 - ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-...Pat Whitworth, Peter D Beitsch, James V Pellicane, Paul L Baron, Laura A Lee
Annals of surgical oncology. 2022-04-19
Press Mentions
Agendia Presents Broad Spectrum of Data from FLEX Study Highlighting Tumor Heterogeneity Within Underrepresented or Underserved Patient Populations at SABCS 2020December 9th, 2020- Real-World Data Explores New Gene Expression Profiles in Breast CancerJanuary 31st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
